Cargando…
Aromatase inhibitor–associated musculoskeletal pain: An overview of pathophysiology and treatment modalities
Since their introduction into clinical use in the 1970s, aromatase inhibitors have been a cornerstone of therapy for estrogen-receptor positive breast cancer in postmenopausal women. Unfortunately, this therapy leads to estrogen depletion in the body, which can lead to unpleasant side effects such a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935546/ https://www.ncbi.nlm.nih.gov/pubmed/35321462 http://dx.doi.org/10.1177/20503121221078722 |